Ge Long Hui·2025-08-29 15:42Core Viewpoint - Spring Medical (01858.HK) reported a significant increase in revenue and net profit for the six months ending June 30, 2025, driven by stable supply of centralized procurement products and expansion in international markets [1] Financial Performance - The company's revenue reached approximately RMB 488 million, representing a year-on-year growth of 28.27% [1] - The net profit attributable to shareholders was approximately RMB 114 million, reflecting a year-on-year increase of 44.85% [1] Business Strategy - The growth in revenue and profit is attributed to the stable supply of centralized procurement products and the deepening of international market expansion [1] - The company has also focused on internal cost reduction and efficiency improvement, enhancing core business competitiveness [1]